|
YBGJ Yubo International Biotech Ltd 895464 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-272,608.00 |
| Balance Sheet |
|
Current Assets
|
$597,823.00 |
|
Assets
|
$709,872.00 |
|
Current Liabilities
|
$3,019,451.00 |
|
Liabilities
|
$3,019,451.00 |
|
Equity
|
$-2,297,615.00 |
|
Shares Out
|
170416343.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-207,157.00 |
| Market Analysis |
Market Cap
|
$1,704,163.43 |
|
Price
|
$0.01 |
|
PB
|
0.16 |
|
FCF
|
$-207,157.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:49 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view YBGJ documents filed with the SEC.
YBGJ Filings
Clear
